Clinical Trial Update: Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion [Phase 1]

View source ↗

Summary

Phase 1 study evaluating surgery followed by intrapleural docetaxel for malignant pleural effusion; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Malignant Pleural Effusion

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University of Virginia | Conditions: Metastatic Cancer | Phase 1 | Status: COMPLETED